145 related articles for article (PubMed ID: 18271660)
1. [Granulocytapheresis in inflammatory bowel disease. Efficacy of an induction plus maintenance sessions protocol at 32 weeks].
Fernández Pérez FJ; Rodríguez F; de Sola C; Fernández Moreno N; Vera F; Rivera R; Sánchez Cantos A
Rev Esp Enferm Dig; 2007 Nov; 99(11):628-35. PubMed ID: 18271660
[TBL] [Abstract][Full Text] [Related]
2. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
[TBL] [Abstract][Full Text] [Related]
3. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.
Naganuma M; Funakoshi S; Sakuraba A; Takagi H; Inoue N; Ogata H; Iwao Y; Ishi H; Hibi T
Inflamm Bowel Dis; 2004 May; 10(3):251-7. PubMed ID: 15290920
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: A useful therapeutic tool not just in ulcerative colitis but also in Crohn's disease.
Fernández-Pérez FJ; Fernández-Moreno N; Soria-López E; Rodriguez-González FJ; Fernández-Galeote FJ; Lifante-Oliva A; Ruíz-Hernández C; Escalante-Quijaite E; Rivas-Ruiz F
Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38710467
[TBL] [Abstract][Full Text] [Related]
5. Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study.
Giampaolo B; Giuseppe P; Michele B; Alessandro M; Fabrizio S; Alfonso C
World J Gastroenterol; 2006 Apr; 12(14):2201-4. PubMed ID: 16610021
[TBL] [Abstract][Full Text] [Related]
6. Treatment of inflammatory bowel disease by leukocytapheresis.
Gerçeker E; Yüceyar H; Kasap E; Demirci U; Ekti BC; Aydoğdu İ; Miskioğlu M
Transfus Apher Sci; 2017 Jun; 56(3):421-426. PubMed ID: 28454883
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis.
Tomomasa T; Kobayashi A; Kaneko H; Mika S; Maisawa S; Chino Y; Syou H; Yoden A; Fujino J; Tanikawa M; Yamashita T; Kimura S; Kanoh M; Sawada K; Morikawa A
Dig Dis Sci; 2003 Apr; 48(4):750-4. PubMed ID: 12741466
[TBL] [Abstract][Full Text] [Related]
9. Adsorptive Monocyte-granulocytapheresis (M-GCAP) for refractory Crohn's disease.
Kusaka T; Fukunaga K; Ohnishi K; Kosaka T; Tomita T; Yokoyama Y; Sawada K; Fukuda Y; Miwa H; Matsumoto T
J Clin Apher; 2004; 19(4):168-73. PubMed ID: 15597346
[TBL] [Abstract][Full Text] [Related]
10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
11. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
[TBL] [Abstract][Full Text] [Related]
12. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
Kopylov U; Ron Y; Avni-Biron I; Koslowsky B; Waterman M; Daher S; Ungar B; Yanai H; Maharshak N; Ben-Bassat O; Lichtenstein L; Bar-Gil Shitrit A; Israeli E; Schwartz D; Zittan E; Eliakim R; Chowers Y; Ben-Horin S; Dotan I
Inflamm Bowel Dis; 2017 Mar; 23(3):404-408. PubMed ID: 28178003
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up.
Caviglia R; Ribolsi M; Rizzi M; Emerenziani S; Annunziata M; Cicala M
World J Gastroenterol; 2007 Oct; 13(39):5238-44. PubMed ID: 17876895
[TBL] [Abstract][Full Text] [Related]
15. Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Sands BE; Sandborn WJ; Wolf DC; Katz S; Safdi M; Schwartz DA; Hanauer SB
J Clin Gastroenterol; 2006 Jul; 40(6):482-9. PubMed ID: 16825929
[TBL] [Abstract][Full Text] [Related]
16. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
Iborra M; Beltrán B; Maroto N; Navarro-Cortés P; Boscá-Watts M; Ferrer-Bradley I; García-Morales N; Sáez-González E; Hinojosa J; Mínguez M; Nos P
Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.
Lindberg A; Eberhardson M; Karlsson M; Karlén P
BMC Gastroenterol; 2010 Jul; 10():73. PubMed ID: 20604939
[TBL] [Abstract][Full Text] [Related]
18. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
[TBL] [Abstract][Full Text] [Related]
19. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
[TBL] [Abstract][Full Text] [Related]
20. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
Edfors K; Ståhlberg D; Söderman C
Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
